U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C23H45NO3
Molecular Weight 383.6083
Optical Activity UNSPECIFIED
Defined Stereocenters 1 / 1
E/Z Centers 1
Charge 0

SHOW SMILES / InChI
Structure of SERINOLAMIDE A

SMILES

CCCCCCCCCCCCC\C=C\CCC(=O)N(C)[C@H](CO)COC

InChI

InChIKey=CJAVPRNATZCNLN-NBRGKURFSA-N
InChI=1S/C23H45NO3/c1-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-23(26)24(2)22(20-25)21-27-3/h16-17,22,25H,4-15,18-21H2,1-3H3/b17-16+/t22-/m1/s1

HIDE SMILES / InChI

Molecular Formula C23H45NO3
Molecular Weight 383.6083
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 1 / 1
E/Z Centers 1
Optical Activity UNSPECIFIED

Approval Year

Substance Class Chemical
Created
by admin
on Sat Dec 16 19:04:19 GMT 2023
Edited
by admin
on Sat Dec 16 19:04:19 GMT 2023
Record UNII
7AX37Z58VV
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
SERINOLAMIDE A
Common Name English
4-OCTADECENAMIDE, N-((1R)-2-HYDROXY-1-(METHOXYMETHYL)ETHYL)-N-METHYL-, (4E)-
Systematic Name English
(4E)-N-[(2R)-1-hydroxy-3-methoxypropan-2-yl]-N-methyloctadec-4-enamide
Systematic Name English
(4E)-N-((1R)-2-HYDROXY-1-(METHOXYMETHYL)ETHYL)-N-METHYL-4-OCTADECENAMIDE
Systematic Name English
Code System Code Type Description
PUBCHEM
56597771
Created by admin on Sat Dec 16 19:04:19 GMT 2023 , Edited by admin on Sat Dec 16 19:04:19 GMT 2023
PRIMARY
FDA UNII
7AX37Z58VV
Created by admin on Sat Dec 16 19:04:19 GMT 2023 , Edited by admin on Sat Dec 16 19:04:19 GMT 2023
PRIMARY
CAS
1342300-14-4
Created by admin on Sat Dec 16 19:04:19 GMT 2023 , Edited by admin on Sat Dec 16 19:04:19 GMT 2023
PRIMARY
EPA CompTox
DTXSID701045276
Created by admin on Sat Dec 16 19:04:19 GMT 2023 , Edited by admin on Sat Dec 16 19:04:19 GMT 2023
PRIMARY
WIKIPEDIA
Serinolamide A
Created by admin on Sat Dec 16 19:04:19 GMT 2023 , Edited by admin on Sat Dec 16 19:04:19 GMT 2023
PRIMARY
Related Record Type Details
TARGET -> AGONIST
TARGET -> AGONIST